Malfunctioning glucose trackers made by Abbott Diabetes Care have been linked to more than 700 severe adverse events and seven potential deaths, the Food and Drug Administration (FDA) and Abbott said.

The FDA designated this a Class I Recall after 860 serious injuries and 7 deaths were reported related to falsely low glucose readings. Abbott Diabetes Care is recalling certain FreeStyle Libre 3 and ...

Abbott Laboratories (NYSE:ABT) reported new FreeDM2 trial results on its FreeStyle Libre continuous glucose monitoring system ...

ABT's Nutrition rebound and FreeStyle Libre growth fuel momentum, but currency swings and macro pressures could cloud ...

Diabetes patients and their families are raising concerns, and in some cases filing lawsuits, after Abbott Diabetes Care recalled glucose monitors linked to seven deaths. In December, Abbott recalled ...

Adults with diabetes using an automated insulin delivery system had minimal change in time in range after switching ...

Abbott Laboratories (NYSE:ABT) ranks among the best most active stocks to buy right now. Following encouraging results from ...

Abbott and MSD announce partnership to distribute sitagliptin brands in India, aiming to strengthen reach in ₹950-1,000 crore diabetes drug segment ...

DexCom is the unrivaled king of the CGM market especially as it relates to various artificial pancreas development efforts. A new deal between Abbott and startup Bigfoot Medical may be the beginnings ...

Hear from three people who live with diabetes as they seek to change the narrative of stigma associated with the chronic condition. Tomeka Porter, 50, has managed her diabetes for over 40 years and ...